Strattera (atomoxetine) Lawsuits and Lawyers handling Strattera lawsuits

What is Strattera?

Health risks to patients caused by lack of warnings and insufficient Strattera clinical trials

Clinical trials are conducted and financed by the pharmaceutical companies.

Severe liver side effects were not noted in the 6,000 patients in the clinical trials that Eli Lilly conducted before approval. Strattera side effects often crop up only after millions of people start using the drug. Lilly estimates that about two million people have used Strattera.

Strattera is the first and only non-stimulant medication approved by FDA for the treatment of ADHD (attention-deficit hyperactivity disorder) in children, adolescents, and adults.

Now that Strattera has been on the market for a few years, more information about the ADHD drug is surfacing. Eli Lilly has warned doctors to stop prescribing Strattera in patients with jaundice or existing liver damage. The updated warning and labeling follows reports of liver problems two patients.

There appears to be more side effects with Strattera than originally revealed. More so, the Strattera side effects appear to be more common and more severe than with stimulant ADD and ADHD prescription drugs.

Clinical trials for Strattera involved only 6,000 patients for short-term testing. Doctors and patients were told that Strattera was safer than traditional stimulant prescription drugs for ADHD. During the clinical trials, there was no reporting of any severe liver damage. Today millions of people take Strattera and new side effects are being made known including acute hepatitis, severe liver damage that may result in the need for liver transplants. Plus the long-term effects of Strattera are still unknown.

Clinical studies, paid for by the pharmaceutical companies, may not reveal every side effect of the drugs that they sell. Still, with out knowing every side effect, if the FDA believes that the clinical benefit outwieghs the known risks, the drugs are still released and marketed. Additional warning labels are often later added when new risks are found. This is often a slow process, considering what is at risk.

There are no wonder drugs: In a recent observational study, parents of children using ADHD medications reported no significant improvement in behavior or performance after one year. This comes as no surprise to parents who have already worked through ADHD medications to no success. Although this study was conducted before Straterra was available to the public, it is important to note that ADHD drugs are not magic pills.

Eli Lilly and Company, a healthcare magnate that earned over $12.5 million in 2003 is responsible for what it has told to physicians and the American public in regards to the safety of prescribing Strattera and its link to liver damage.

If you or a family member has taken Strattera and liver damage has been diagnosed, contact an expert Strattera lawyer today for a free NO-OBLIGATION inquiry or fill out the below form.